Report Highlights
The global market for drugs of abuse (DOA) testing is estimated to increase from $5.2 billion in 2022 to reach $8.1 billion by 2027, at a compound annual growth rate (CAGR) of 9.3% from 2022 through 2027.
Report Includes
- 23 data tables and 42 additional tables
- A comprehensive overview and an up-to-date analysis of the global markets for drugs of abuse (DOA) testing
- Analyses of the global market trends, with historic market revenue (sales figures) for 2021, estimates for 2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the upcoming market potential for DOA testing industry along with a detailed analysis of the competitive environment, industry trends, opportunities and penetration of emerging technologies within the marketplace
- Estimation of the actual market size and revenue forecast for the global drug abuse testing market in USD million values, and its corresponding market share analysis based on the product, sample type, drug type, testing type, end user, and region
- Technology assessment of the current and possible future legislation affecting the market in the U.S. and other emerging economies, and their influence in the market developments
- Statistical information covering drug abuse along with its trends as well as drug classes across the key geographic regions
- A comparative study and Porter’s Five Forces analysis considering both the micro and macro environmental factors prevailing in the market for drugs of abuse testing
- Review of the key patent grants and patent applications on drug abuse testing technologies
- Identification of the major stakeholders and analysis of the company competitive landscape based on their recent market developments, financial performance, and segmental revenues
- Descriptive company profiles of the leading global players, including Abbott Laboratories, Beckmann Coulter (Danaher Corp.), Roche Diagnostics, Quest Diagnostics Inc., LifeSign and Thermo Fisher Scientific Inc.
Report Scope
The current report offers a detailed picture of the drug abuse testing market.
This report highlights the current and future market potential for drug abuse testing and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2027 and key market players.
This report discusses drug abuse testing and its various resources. It covers the overall drug abuse testing market, including drug testing products. The report further analyzes the market based on products, covering analyzers, consumables, laboratory services, and point-of-care devices. In addition, the report also analyzes various sample types in drug abuse testing that include blood, hair, sweat, oral, urine, and others. Furthermore, a complete regional analysis of the market is also presented in the report.
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World (which includes Latin America, the Middle East and Africa). Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China, and India) are covered in regional segments. For market estimates, data has been provided for 2021 as the base year, with forecasts for 2022 through 2027. Estimated values are based on revenue generated by drug abuse testing companies as total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||||||||||||||
| Forecast period considered | 2022-2027 | ||||||||||||||||||||||||||||||
| Base year market size | $4.8 billion | ||||||||||||||||||||||||||||||
| Market size forecast | $8.1 billion | ||||||||||||||||||||||||||||||
| Growth rate | CAGR of 9.3% for the forecast period of 2022-2027 | ||||||||||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||||||||||
| Segments covered | By Product, Sample Type, Drug Type, Testing Type, End User, and Region | ||||||||||||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||||||||||||||||||||||
| Countries covered | U.S., Canada, Germany, U.K., France, Japan, China and India | ||||||||||||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||||||||||||
Frequently Asked Questions (FAQs)
- Government initiatives for drug abuse testing
- Increased drug trafficking
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Regional Analysis of the Beauty and Personal Care Market: Middle East and North Africa (HLC305A)
- Global Biochip Markets: Microarrays and Lab-on-a-Chip (BIO049G)
- Contract Manufacturing: Global Markets to 2030 (MFG062B)
- Global Markets for Allergy Diagnostics and Treatments (PHM026D)
- Global Markets for Telemedicine Technologies (HLC014M)
Related Reports
Breakthrough Therapies: Market Dynamics and Investment Opportunities
The global market for breakthrough therapy drugs was valued at $133.3 billion in 2023. This market is expected to grow from $150.6 billion in 2024 to $287.5 billion by 2029, at a compound annual growth rate (CAGR) of 13.8% from 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
3D Cell Cultures: Technologies and Global Markets
The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.
Blood Testing: Technologies and Global Markets
The global market for blood testing will grow from nearly $53.8 billion in 2018 to $60.5 billion by 2023 with a compound annual growth rate (CAGR) of 2.4% for the period of 2018-2023.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Global Markets for Allergy Diagnostics and Treatments
The global market for allergy diagnostics and treatment is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual rate growth (CAGR) of 7.3% from 2025 through 2030.
Over-the-Counter (OTC) Drugs, and Vitamins & Dietary Supplements: Global Markets
The global market for over-the- counter (OTC) drugs, vitamins and dietary supplements is expected to grow from $276.9 billion in 2025 and is projected to reach $371.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2025 to 2030.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.
The Global Influenza Market
The global influenza market is expected to grow from $9.0 billion in 2024 and is projected to reach $12.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.2% during the forecast period of 2024 to 2029.
Liver Disease Treatments: The Global Market
The global market for liver disease treatments is estimated to increase from $46.0 billion in 2024 to reach $69.1 billion by 2030, at a compound annual growth rate (CAGR) of 7.1% from 2025 through 2030.
Top Trending Reports
Next-Generation Advanced Batteries: Global Markets
The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Report Highlights
The global market for drugs of abuse (DOA) testing should grow from $3.5 billion in 2018 to $4.6 billion by 2023 with a compound annual growth rate (CAGR) of 5.6% for the period of 2018-2023.
Report Includes
- 32 data tables and 49 additional tables
- An industry analysis of the global market for drug testing technologies within the pharmaceutical industry
- Analyses of global market trends, with data from 2017, 2018 and projections of compound annual growth rates (CAGRs) through 2023
- Statistical information pertaining to drug abuse along with its trends as well as drug classes in key geographic regions
- Information on leading players in the market and their key products
- Sales projections through 2023 for drug of abuse testing markets by sample matrix and geographic regions
- Technological assessment of the current and possible future legislation affecting the market in the U.S. and other emerging economies, and examines the influence of these acts in the development of the industry
- Company profiles of major global players operating within the drug development market, including Ortho-Clinical Diagnostics, Randox Toxicology, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Thermo Fisher Scientific Inc., Quest Diagnostics, and Abbott Laboratories
Report Highlights
The global drug of abuse (DOA) testing market reached nearly $3.0 billion in 2016. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach nearly $3.9 billion by 2022 from $3.1 billion in 2017.
Report Includes
- An overview of the global market for drug testing technologies.
- Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
- An overview of drug abuse trends in terms of various geographic regions as well as drug classes.
- Information on leading players in the market and their key products.
- Analysis of leading companies in the field and their successful strategies.
Report Highlights
The global drug of abuse (DOA) testing market reached nearly $2.8 billion in 2014. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach almost $3.5 billion by 2019.
Report Includes
- An overview of the global market for drug testing technologies.
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
- An overview of drug abuse trends in terms of various geographic regions as well as drug classes.
- Information on leading players in the market and their key products.
- Analysis of leading companies in the field and their successful strategies.
Report Highlights
- The global market for DOA testing increased from $1.9 billion in 2007 to an estimated $2.0 billion by the end of 2008. It should reach $2.6 billion in 2014, for a compound annual growth rate (CAGR) of 4.6%.
- The U.S. testing market segment generated the largest share of revenues with $1.4 billion in 2007. This is expected to reach $1.5 billion in 2008 and $2.0 billion in 2014, for a CAGR of 5.2%.
- The European Union had the second largest market segment with $365.2 million in sales in 2007. This is expected to grow at a CAGR of 2.9% to reach $374.2 million in 2008 and $445.9 million in 2014.
Report Highlights
- Drugs of abuse testing sales will reach $1.6 billion in 2007, rising at an AAGR (average annual growth rate) of 4.7%.
- Sales in the U.S. are expected to reach $996 million in 2002 and forecasted to grow to $1.3 billion in 2007 at an AAGR of 5.4%.
- Sales in Europe expected to be $291 million in 2002 and forecasted to grow at an AAGR of 1.8% to approximately $318 million in 2007.
- The number of different places and applications, such as a workplace, drug court, hospital, and school, for drug testing, with blood, hair, oral fluid, sweat or urine samples, reflects the need for a variety of drug testing services and the versatility of drug testing technology.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More